JP2021505136A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505136A5 JP2021505136A5 JP2020530325A JP2020530325A JP2021505136A5 JP 2021505136 A5 JP2021505136 A5 JP 2021505136A5 JP 2020530325 A JP2020530325 A JP 2020530325A JP 2020530325 A JP2020530325 A JP 2020530325A JP 2021505136 A5 JP2021505136 A5 JP 2021505136A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain
- cys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023133670A JP7620676B2 (ja) | 2017-12-04 | 2023-08-18 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
| JP2025003895A JP2025072378A (ja) | 2017-12-04 | 2025-01-10 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762594244P | 2017-12-04 | 2017-12-04 | |
| US62/594,244 | 2017-12-04 | ||
| PCT/US2018/063581 WO2019112941A1 (en) | 2017-12-04 | 2018-12-03 | Hla class i-restricted t cell receptors against mutated ras |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023133670A Division JP7620676B2 (ja) | 2017-12-04 | 2023-08-18 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505136A JP2021505136A (ja) | 2021-02-18 |
| JP2021505136A5 true JP2021505136A5 (https=) | 2022-01-11 |
| JP7385566B2 JP7385566B2 (ja) | 2023-11-22 |
Family
ID=64949411
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020530325A Active JP7385566B2 (ja) | 2017-12-04 | 2018-12-03 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
| JP2023133670A Active JP7620676B2 (ja) | 2017-12-04 | 2023-08-18 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
| JP2025003895A Pending JP2025072378A (ja) | 2017-12-04 | 2025-01-10 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023133670A Active JP7620676B2 (ja) | 2017-12-04 | 2023-08-18 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
| JP2025003895A Pending JP2025072378A (ja) | 2017-12-04 | 2025-01-10 | 突然変異ｒａｓに対するｈｌａクラスｉ拘束性ｔ細胞受容体 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11466071B2 (https=) |
| EP (1) | EP3720478A1 (https=) |
| JP (3) | JP7385566B2 (https=) |
| KR (1) | KR20200115484A (https=) |
| CN (2) | CN111836638B (https=) |
| AU (2) | AU2018378200B2 (https=) |
| BR (1) | BR112020011111A2 (https=) |
| CA (1) | CA3084246A1 (https=) |
| CR (1) | CR20200287A (https=) |
| EA (1) | EA202091335A1 (https=) |
| IL (1) | IL275031A (https=) |
| MA (2) | MA51043A (https=) |
| MX (1) | MX2020005765A (https=) |
| SG (1) | SG11202005236QA (https=) |
| WO (1) | WO2019112941A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018269370B2 (en) * | 2017-05-16 | 2025-06-05 | The Johns Hopkins University | Manabodies and methods of using |
| WO2020154617A1 (en) * | 2019-01-25 | 2020-07-30 | The Trustees Of The University Of Pennsylvania | Compositions and methods for targeting mutant ras |
| CN114026116A (zh) * | 2019-02-20 | 2022-02-08 | 弗雷德哈钦森癌症研究中心 | Ras新抗原特异性结合蛋白及其用途 |
| EP3760217A1 (en) | 2019-07-01 | 2021-01-06 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Cd5 specific t cell receptor cell or gene therapy |
| CN112646024B (zh) * | 2019-10-10 | 2023-03-24 | 香雪生命科学技术（广东）有限公司 | 一种识别kras突变的t细胞受体及其编码序列 |
| CN112759641B (zh) * | 2019-11-01 | 2023-01-20 | 香雪生命科学技术（广东）有限公司 | 一种识别Kras G12V的高亲和力TCR |
| CN115279784A (zh) * | 2020-02-12 | 2022-11-01 | 美国卫生和人力服务部 | 针对含有g12d突变的ras的hla i类限制性t细胞受体 |
| KR20220143875A (ko) * | 2020-02-14 | 2022-10-25 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | G12v 돌연변이를 갖는 ras에 대한 hla 클래스 i-제한된 t 세포 수용체 |
| EP4110804A1 (en) * | 2020-02-26 | 2023-01-04 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Hla class ii-restricted t cell receptors against ras with g12v mutation |
| AU2021309958A1 (en) * | 2020-07-16 | 2023-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | HLA class II-restricted DRB T cell receptors against RAS with G12V mutation |
| TW202229327A (zh) * | 2020-10-02 | 2022-08-01 | 美國衛生與公眾服務部 | 針對含有g13d突變之ras之hla第ii類限制性dq t細胞受體 |
| KR102488353B1 (ko) * | 2020-10-08 | 2023-01-12 | 부산대학교 산학협력단 | 돌연변이 kras를 표적하는 펩타이드 및 이의 용도 |
| US20240000834A1 (en) * | 2020-11-24 | 2024-01-04 | Shanghai GenBase Biotechnology Co., Ltd. | Ras mutant epitope peptide and t cell receptor recognizing ras mutant |
| WO2022183167A1 (en) | 2021-02-25 | 2022-09-01 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| CN117545766A (zh) * | 2021-05-25 | 2024-02-09 | 纪念斯隆-凯特琳癌症中心 | 靶向ras突变的t细胞受体及其用途 |
| JP2025504883A (ja) | 2022-01-21 | 2025-02-19 | テ－クニフェ ゲーエムベーハー | 決定可能な親和性で特定のペプチドを結合する抗原認識コンストラクト、およびｋｒａｓに抗原特異性を有するｔ細胞レセプター、ならびに、対応する核酸配列、ベクター、宿主細胞、医薬組成物、およびキット |
| US20250145950A1 (en) | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
| CN117264043B (zh) * | 2022-06-14 | 2024-05-10 | 上海镔铁生物科技有限责任公司 | 靶向kras g12v突变多肽的t细胞受体及其用途 |
| CN115850444B (zh) * | 2022-09-15 | 2025-01-28 | 重庆医科大学 | Tcr或其抗原结合片段及其应用 |
| CN115960204B (zh) * | 2022-11-04 | 2023-08-25 | 新景智源生物科技(苏州)有限公司 | Kras_g12v突变抗原特异性tcr及其与cd8共表达重定向cd4 t细胞 |
| CN118852452A (zh) * | 2023-04-28 | 2024-10-29 | 北京鼎成肽源生物技术有限公司 | 靶向kras g12突变的tcr分子和细胞及其应用 |
| CN118909132A (zh) * | 2023-05-06 | 2024-11-08 | 北京鼎成肽源生物技术有限公司 | 靶向kras g12v突变的tcr分子和细胞及其应用 |
| WO2025056672A1 (en) * | 2023-09-15 | 2025-03-20 | Medigene Immunotherapies Gmbh | T-CELL RECEPTOR VARIANT AGAINST mKRAS7-16 G12V |
| WO2025056681A1 (en) * | 2023-09-15 | 2025-03-20 | Medigene Immunotherapies Gmbh | T-CELL RECEPTOR AGAINST mKRAS7-16 G12V AND G12C |
| EP4570263A1 (en) * | 2023-12-15 | 2025-06-18 | Genovie AB | Tcrs recognizing g12v mutated ras and uses thereof |
| WO2025125590A2 (en) * | 2023-12-15 | 2025-06-19 | Genovie Ab | Tcr recognizing g12v mutated ras and uses thereof |
| WO2026024602A2 (en) * | 2024-07-22 | 2026-01-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors against ras with g12d, g12v, g13d or q61r mutation |
| CN119350472B (zh) * | 2024-12-25 | 2025-04-04 | 北京可瑞生物科技有限公司 | 修饰的靶向kras g12v的t细胞受体或其片段以及用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8034334B2 (en) | 2002-09-06 | 2011-10-11 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy |
| US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
| CN103124740B (zh) * | 2010-09-21 | 2015-09-02 | 美国卫生和人力服务部 | 抗-ssx-2t细胞受体和相关材料及使用方法 |
| US20120244133A1 (en) | 2011-03-22 | 2012-09-27 | The United States of America, as represented by the Secretary, Department of Health and | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
| CN118994363A (zh) * | 2014-11-26 | 2024-11-22 | 美国卫生和人力服务部 | 抗突变的kras的t细胞受体 |
| ES2879287T3 (es) * | 2015-09-15 | 2021-11-22 | Us Health | Receptores de células T que reconocen KRAS mutado restringido a HLA-cw8 |
| WO2017112944A1 (en) * | 2015-12-23 | 2017-06-29 | Fred Hutchinson Cancer Research Center | High affinity t cell receptors and uses thereof |
| TWI752930B (zh) * | 2015-12-23 | 2022-01-21 | 德商梅迪基因免疫治療公司 | 抗原特異性ｔｃｒ的新生成 |
| WO2019112932A1 (en) * | 2017-12-04 | 2019-06-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching cell populations for cancer-specific t cells using in vitro stimulation of memory t cells |
-
2018
- 2018-12-03 CR CR20200287A patent/CR20200287A/es unknown
- 2018-12-03 EP EP18830062.8A patent/EP3720478A1/en active Pending
- 2018-12-03 WO PCT/US2018/063581 patent/WO2019112941A1/en not_active Ceased
- 2018-12-03 CN CN201880087270.7A patent/CN111836638B/zh active Active
- 2018-12-03 MA MA051043A patent/MA51043A/fr unknown
- 2018-12-03 CA CA3084246A patent/CA3084246A1/en active Pending
- 2018-12-03 EA EA202091335A patent/EA202091335A1/ru unknown
- 2018-12-03 JP JP2020530325A patent/JP7385566B2/ja active Active
- 2018-12-03 US US16/769,144 patent/US11466071B2/en active Active
- 2018-12-03 BR BR112020011111-2A patent/BR112020011111A2/pt unknown
- 2018-12-03 MX MX2020005765A patent/MX2020005765A/es unknown
- 2018-12-03 KR KR1020207019185A patent/KR20200115484A/ko not_active Ceased
- 2018-12-03 MA MA051042A patent/MA51042A/fr unknown
- 2018-12-03 SG SG11202005236QA patent/SG11202005236QA/en unknown
- 2018-12-03 AU AU2018378200A patent/AU2018378200B2/en active Active
- 2018-12-03 CN CN202411410030.XA patent/CN119162251A/zh active Pending
-
2020
- 2020-06-01 IL IL275031A patent/IL275031A/en unknown
-
2022
- 2022-09-12 US US17/931,391 patent/US20230026180A1/en active Pending
-
2023
- 2023-08-18 JP JP2023133670A patent/JP7620676B2/ja active Active
-
2025
- 2025-01-10 JP JP2025003895A patent/JP2025072378A/ja active Pending
- 2025-05-13 AU AU2025203455A patent/AU2025203455A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505136A5 (https=) | ||
| JP2020534828A5 (https=) | ||
| JP2018535647A5 (https=) | ||
| JP2015535816A5 (https=) | ||
| Takamiya et al. | HLA-B* 3501–peptide interactions: role of anchor residues of peptides in their binding to HLA-B* 3501 molecules | |
| GB2609760A (en) | HLA Class I-restricted T cell receptors against RAS with G12D mutation | |
| US8647865B2 (en) | Promiscuous PAP CD4 T cell epitopes | |
| JP2023527613A (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2022523024A5 (https=) | ||
| CN113621048A (zh) | T细胞抗原受体、其多聚体复合物及其制备方法和应用 | |
| JP2023534241A5 (https=) | ||
| Baron et al. | Antibodies against a synthetic peptide of the poliovirus replicase protein: reaction with native, virus-encoded proteins and inhibition of virus-specific polymerase activities in vitro | |
| McCluskey et al. | Cell surface expression of an in vitro recombinant class II/class I major histocompatibility complex gene product | |
| AU2005230425B2 (en) | Stabilised Tat antigen and the use thereof for anti-HIV vaccination | |
| CA2660178C (en) | Promiscuous her-2/neu cd4 t cell epitopes | |
| Deckhut et al. | Localization of common cytotoxic T lymphocyte recognition epitopes on simian papovavirus SV40 and human papovavirus JC virus T antigens | |
| JP2023535366A5 (https=) | ||
| CN108948203A (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2023540123A5 (https=) | ||
| NZ805541A (en) | Hla class i-restricted t cell receptors against mutated ras | |
| CN114524870A (zh) | 源自于ssx2抗原的短肽 | |
| CN118852387A (zh) | 源自于mage a4的肿瘤抗原肽及其复合物 | |
| CN118852386A (zh) | 一种衍生自mage a4的肽及其复合物 | |
| IL279463A (en) | Coronavirus derived peptides and uses thereof | |
| JP2003024069A (ja) | ＴｄＴ結合性新規タンパク質および当該タンパク質をコードする遺伝子 |